Article List

WPRIM Management System> DCMS> Clinical and Molecular Hepatology> 2017> 23> 1

Volume: 23 Issue: 1

1. Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma.	Page:95—101
2. Epithelioid angiomyolipoma of the liver: a case report.	Page:91—94
3. Hepatogastric fistula as a rare complication of pyogenic liver abscess.	Page:87—90
4. Hepatic perivascular epithelioid cell tumor (PEComa): a case report with a review of literatures.	Page:80—86
5. Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study.	Page:74—79
6. Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients.	Page:66—73
7. A lexicon for hepatocellular carcinoma surveillance ultrasonography: benign versus malignant lesions.	Page:57—65
8. Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study.	Page:51—56
9. The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE.	Page:42—50
10. Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis.	Page:34—41
11. Is scheduled second chemoembolization necessary for early stage hepatocellular carcinoma showing complete response after first chemoembolization?.	Page:31—33
12. Transient elastography can be integrated into routine clinical practice for the evaluation of portal hypertension?.	Page:27—30
13. The use of immunosuppression in autoimmune hepatitis: A current literature review.	Page:22—26
14. Anticoagulation in cirrhosis: a new paradigm?.	Page:13—21
15. Genetic predisposition in nonalcoholic fatty liver disease.	Page:1—12